A Eugin study wins the Clinical Science Award for best clinical poster at ESHRE 2019 Blog Post

The fresh or frozen eggs of the same woman are equally fertile. This is the main conclusion of a study conducted by Eugin Group researchers which won the Clinical Science Award for best clinical poster at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). The research went head-to-head with 800 other studies, and its principal investigator was David Cornet-Bartolomé, a member of Eugin’s Basic Research Laboratory headquartered in the Barcelona Science Park.

 

The GAEM ‘Value Company’ Certification is launched Blog Post

GAEM Foundation, based in the Parc Científic de Barcelona Science Park, has launched the GAEM ‘Value Company’ Certification, recognising the most avant-garde companies committed to Corporate Social Responsibility (CSR) and social well-being. With this seal, the foundation aims to continue promoting biomedical research to cure multiple sclerosis and contribute to raising awareness of the importance of innovation and science in our society. 

 

Scientists at IRB Barcelona can simulate and predict the shape of a molecule in function of its environment Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park hows that computer simulations can predict the shape of a molecule in function of its environment. The research results, published in Angewandte Chemies, mark a milestone for the computational design of molecules with specific shape and features for agrochemical, technological and pharmaceutical applications.

 

The European project GLAM develops a multiplexed biosensor for personalized diagnosis and therapy for bladder cancers Blog Post

A European consortium led by Centre Tecnològic Leitat –through its Biomed Division in the Barcelona Science Park (PCB)– has finished the GLAM project, the aim of which was to develop a photonic biosensor for a non-invasive diagnosis and personalized therapy for bladder cancers. The project involved the participation of 10 European organizations with resources and capabilities from the academia and scientific and business field, among them the Institute for Bioengineering of Catalonia (IBEC), which is also located in PCB.

 

CataloniaBio & HealthTech and Boston MassMEDIC join forces Blog Post

CataloniaBio & HealthTech –the association of companies in the biomedicine and health arena in Catalonia, based in the Barcelona Science Park– and the Massachusetts Medical Device Industry Council (MassMEDIC), the largest association of medical technology companies in the United States, have signed an agreement to foster innovation and collaborations in business and research among their members. 

 

The BSC-IRB researcher Toni Gabaldón, vice president of the new Young Academy of Spain Blog Post

The Young Academy of Spain has been constituted today in the Ministry of Science, Innovation and Universities with the aim of representing and giving visibility to young scientists, preferably from the field of experimental sciences. One of the founding members and vice president of this new scientific institution is ICREA researcher Toni Gabaldón, with double affiliation to the Barcelona Supercomputing Center (BSC-CNS) and IRB Barcelona, leading the Comparative Genomics group.

 

The hippocampus orchestrates the cerebral process that allows us to recall memories Blog Post

For the first time in humans, researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park have simultaneously recorded the brain activity of the two key areas linked to memory: the hippocampus and the neocortex. This study was made possible thanks to the voluntary participation of epilepsy patients who, due to their disease, have intracranial electrode implants. Making use of virtual reality, the participants performed spatial memory tasks. 

 

Bionure launches a crowdfunding campaign to fund the preparation the phase 2 study of BN201 Blog Post

Bionure, a biotech company specialized in neuroprotection based in the Barcelona Science Park, has launched a crowdfunding campaign through the Spanish platform of Capital Cell with the objective of raising €1.3M that will be used to finance the preparation of the phase 2 study of its neuroprotectant BN201. The campaign (multiplesmotivos.com) is part of a bridge round of €2.4M that will cover the expenses of regulatory and technical preparation of the phase 2 study.

 

GlyCardial Diagnostics wins the EmprendedorXXI 2019 Award in the ‘Health Tech’ category Blog Post

GlyCardial Diagnostics has won the  the EmprendedorXXI Award in the ‘Health Tech’ category, one of the six awards granted in its twelfth year to recognize those companies in Spain and Portugal with greatest growth potential in several sectors linked to the new innovation trends. The winners have been selected from 961 companies in Spain and Portugal. The biotechnology company, headquartered in the Barcelona Science Park, adds this award to the EmprendedorXXI Award in Catalonia, which it received on 9 May.